Associated Papers
Estrogen receptor mutations found in breast cancer metastases integrated with the molecular pharmacology of selective ER modulators.
Jordan VC et al.
Journal of the National Cancer Institute, 2015
Role of aspartate 351 in transactivation and active conformation of estrogen receptor alpha.
Kim JH et al.
Journal of Molecular Endocrinology, 2005
Estrogenic effects of resveratrol in breast cancer cells expressing mutant and wild-type estrogen receptors: role of AF-1 and AF-2.
Gehm BD et al.
The Journal of Steroid Biochemistry and Molecular Biology, 2004
Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
MacGregor Schafer J et al.
Cancer Research, 2000
Control of the estrogen-like actions of the tamoxifen-estrogen receptor complex by the surface amino acid at position 351.
Levenson AS et al.
The Journal of Steroid Biochemistry and Molecular Biology, 0
Select a paper to view details